Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving glucose or galactose
Reexamination Certificate
2001-02-15
2002-12-03
Gitomer, Ralph (Department: 1627)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving glucose or galactose
C435S028000, C422S051000
Reexamination Certificate
active
06489133
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to a test device and method for the colorimetric determination of chemical and biochemical components (analytes) in aqueous fluids, particularly whole blood. In one preferred embodiment it concerns a test device and method for colorimetrically measuring the concentration of glucose in whole blood.
BACKGROUND OF THE INVENTION
The quantification of chemical and biochemical components in colored aqueous fluids, in particular colored biological fluids such as whole blood and urine and biological fluid derivatives such as blood serum and blood plasma, is of ever-increasing importance. Important applications exist in medical diagnosis and treatment and in the quantification of exposure to therapeutic drugs, intoxicants, hazardous chemicals and the like. In some instances, the amounts of materials being determined are either so miniscule——in the range of a microgram or less per deciliter——or so difficult to precisely determine that the apparatus employed is complicated and useful only to skilled laboratory personnel. In this case the results are generally not available for some hours or days after sampling. In other instances, there is often an emphasis on the ability of lay operators to perform the test routinely, quickly and reproducibly outside a laboratory setting with rapid or immediate information display.
One common medical test is the measurement of blood glucose levels by diabetics. Current teaching counsels diabetic patients to measure their blood glucose level from two to seven times a day depending on the nature and severity of their individual cases. Based on the observed pattern in the measured glucose levels, the patient and physician together make adjustments in diet, exercise and insulin intake to better manage the disease. Clearly, this information should be available to the patient immediately.
Currently a method widely used in the United States employs a test article of the type described in U.S. Pat. No. 3,298,789 issued Jan. 17, 1967 to Mast. In this method a sample of fresh, whole blood (typically 20-40 &mgr;l) is placed on an ethylcellulose-coated reagent pad containing an enzyme system having glucose oxidase and peroxidase activity. The enzyme system reacts with glucose and releases hydrogen peroxide. The pad also contains an indicator which reacts with the hydrogen peroxide in the presence of peroxidase to give a color proportional in intensity to the sample's glucose level.
Another popular blood glucose test method employs similar chemistry but in place of the ethylcellulose-coated pad employs a water-resistant film through which the enzymes and indicator are dispersed. This type of system is disclosed in U.S. Pat. No. 3,630,957 issued Dec. 28, 1971 to Rey et al.
In both cases the sample is allowed to remain in contact with the reagent pad for a specified time (typically one minute). Then in the first case the blood sample is washed off with a stream of water while in the second case it is wiped off the film. The reagent pad or film is then blotted dry and evaluated. The evaluation is made either by comparing color generated with a color chart or by placing the pad or film in a diffuse reflectance instrument to read a color intensity value.
While the above methods have been used in glucose monitoring for years, they do have certain limitations. The sample size required is rather large for a finger stick test and is difficult to achieve for some people whose capillary blood does not express readily.
In addition, these methods share a limitation with other simple lay-operator colorimetric determinations in that their result is based on an absolute color reading which is in turn related to the absolute extent of reaction between the sample and the test reagents. The fact that the sample must be washed or wiped off the reagent pad after the timed reaction interval requires that the user be ready at the end of the timed interval and wipe or apply a wash stream at the required time. The fact that the reaction is stopped by removing the sample leads to some uncertainty in the result, especially in the hands of the home user. Overwashing can give low results and underwashing can give high results.
Another problem that often exists in simple lay-operator colorimetric determinations is the necessity for initiating a timing sequence when blood is applied to a reagent pad. A user will typically have conducted a finger stick to obtain a blood sample and will then be required to simultaneously apply the blood from the finger to a reagent pad while initiating a timing circuit with his or her other hand, thereby requiring the use of both hands simultaneously. This is particularly difficult since it is often necessary to insure that the timing circuit is started only when blood is applied to the reagent pad. All of the prior art methods require additional manipulations or additional circuitry to achieve this result. Accordingly, simplification of this aspect of reflectance reading instruments is desirable.
The presence of red blood cells or other colored components often interferes with the measurements of these absolute values, thereby calling for exclusion of red blood cells in these two prior methods as they are most widely practiced. In the device of U.S. Pat. No. 3,298,789 an ethyl cellulose membrane prevents red blood cells from entering the reagent pad. Similarly, the water-resistant film of U.S. Pat. No. 3,630,957 prevents red blood cells from entering the pad. In both cases the rinse or wipe also acts to remove these potentially interfering red blood cells prior to measurement.
Accordingly, there remains a need for a system of detecting analytes in colored liquids, such as blood, that does not require removal of excess liquid from a reflectance strip from which a reflectance reading is being obtained.
SUMMARY OF THE INVENTION
Novel methods, compositions and apparatus are provided for diagnostic assays comprising a hydrophilic porous matrix containing a signal producing system and a reflectance measuring apparatus which is activated upon a change in reflectance of the matrix when fluid penetrates the matrix. The method comprises adding the sample, typically whole blood, to the matrix which filters out large particles, such as red blood cells, typically with the matrix present in the apparatus. The signal-producing system produces a product which further changes the reflectance of the matrix, which change can be related to the presence of an analyte in a sample.
Exemplary of the diagnostic assay system is the determination of glucose in the whole blood, where the determination is made without interference from the blood and without a complicated protocol subject to use error.
REFERENCES:
patent: 2369499 (1945-02-01), Treuhaft
patent: 3604815 (1971-09-01), Clemens
patent: 3658480 (1972-04-01), Kane et al.
patent: 3709612 (1973-01-01), Clemens
patent: 3769178 (1973-10-01), Rothermel, Jr.
patent: 4218144 (1980-08-01), Whitehouse et al.
patent: 4373818 (1983-02-01), Yamamoto et al.
patent: 4518259 (1985-05-01), Ward
patent: 4523853 (1985-06-01), Rosenbladt et al.
patent: 4935346 (1990-06-01), Phillips et al.
patent: 5178831 (1993-01-01), Sakota et al.
patent: 5179005 (1993-01-01), Phillips et al.
patent: 5246858 (1993-09-01), Arbuckle et al.
patent: 5379214 (1995-01-01), Arbuckle et al.
patent: 5426032 (1995-06-01), Phillips et al.
patent: 5563042 (1996-10-01), Phillips et al.
patent: 5843692 (1998-12-01), Phillips et al.
patent: 5866349 (1999-02-01), Lilja et al.
patent: 5962215 (1999-10-01), Douglas et al.
patent: 5968760 (1999-10-01), Phillips et al.
patent: 5997817 (1999-12-01), Crismore et al.
patent: 6268162 (2001-07-01), Phillips et al.
patent: 1117784 (1982-09-01), None
patent: 0 113 896 (1983-12-01), None
patent: 0 133 481 (1984-07-01), None
patent: 2.191.734 (1974-02-01), None
patent: 1 440 464 (1976-06-01), None
patent: 1 508 576 (1978-04-01), None
patent: 55-136957 (1980-10-01), None
patent: 62-22066 (1987-01-01), None
Adler et al., Entitled “Automatic Coagulation Profile System,” Technicon Internat
Jurik Franklin A.
McGarraugh Geoffery
Phillips Roger
Underwood Raymond D.
Bozicevic, Field & Francis
Gitomer Ralph
LifeScan, Inc.
Tall Susan
LandOfFree
Apparatus for determinating the concentration of glucose in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apparatus for determinating the concentration of glucose in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apparatus for determinating the concentration of glucose in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2991729